Molecular screening to select therapy for advanced cancer?
Abstract
In this issue of Annals of Oncology, Trédan et al. [1.Trédan O. Wang Q. Pissaloux D. et al.Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial.Ann Oncol. 2019; 30: 757-765Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar] describe the results of the ProfiLER trial, in which 2579 adult and paediatric patients with previously treated...
Paper Details
Title
Molecular screening to select therapy for advanced cancer?
Published Date
May 1, 2019
Journal
Volume
30
Issue
5
Pages
661 - 663
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History